Technology
Health
Biotechnology
InflaRx
$43.009876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$43.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.68 (-1.56%) Today
-$0.01 (-0.02%) After Hours
Why Robinhood?
You can buy or sell InflaRx and other stocks, options, ETFs, and crypto commission-free!
About
InflaRx N.V. Common Stock, also called InflaRx, is a biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Read More Its pipeline includes IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
Employees
—
Headquarters
Jena, Thueringen
Founded
2007
Market Cap
1.13B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
58.46K
High Today
$43.67
Low Today
$42.26
Open Price
$43.25
Volume
52.04K
52 Week High
$51.33
52 Week Low
$20.31
Collections
Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2017 IPO
Europe (Non-UK)
Europe
News
Simply Wall StMar 8
Do Insiders Own Lots Of Shares In InflaRx N.V. (NASDAQ:IFRX)?
Every investor in InflaRx N.V. (NASDAQ:IFRX) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. I quite like to see at least a little bit of insider ownership. As Charlie Munger said ‘Show me the incentive and I will show you the outcome.’ InflaRx has a market capitalization of US$1.1b, so we would expect some institutional investors to have noticed the st...
Price Paid on Robinhood
18% Higher
Right Now
52 Week Low
$20.31
Average Price Paid
$36.37
52 Week High
$51.33
Earnings
-$0.41
-$0.31
-$0.22
-$0.12
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
—
Actual
Expected Mar 28, Pre-Market